VILLELLA, VALERIA RACHELA
 Distribuzione geografica
Continente #
NA - Nord America 397
EU - Europa 183
AS - Asia 130
AF - Africa 4
OC - Oceania 2
SA - Sud America 1
Totale 717
Nazione #
US - Stati Uniti d'America 388
IT - Italia 120
SG - Singapore 76
CN - Cina 50
FI - Finlandia 16
NL - Olanda 12
IE - Irlanda 9
CA - Canada 8
DE - Germania 7
FR - Francia 6
CI - Costa d'Avorio 4
IN - India 4
ES - Italia 3
GB - Regno Unito 3
UA - Ucraina 3
AU - Australia 2
SE - Svezia 2
CO - Colombia 1
HR - Croazia 1
HU - Ungheria 1
PA - Panama 1
Totale 717
Città #
Chandler 109
Singapore 61
Napoli 45
Millbury 29
Naples 23
Santa Clara 20
Ashburn 14
Princeton 13
Amsterdam 12
Des Moines 12
Nanjing 12
Lawrence 9
Beijing 8
Ottawa 8
Jacksonville 7
Boston 6
Cagliari 6
Nanchang 5
Houston 4
Lappeenranta 4
Tarragona 3
Wilmington 3
Woodbridge 3
Bologna 2
Brisbane 2
Hebei 2
Jiaxing 2
Kronberg 2
Maglie 2
Messina 2
Milan 2
Norwalk 2
Poggiomarino 2
Pune 2
Redwood City 2
Shenyang 2
Torino 2
Bhubaneswar 1
Bogotá 1
Boydton 1
Budapest 1
Caserta 1
Casoria 1
Changsha 1
Dublin 1
Falls Church 1
Formia 1
Fremont 1
Hangzhou 1
Kunming 1
Lagundo 1
Lauria 1
Leicester 1
Livorno 1
London 1
Los Angeles 1
Monopoli 1
Munich 1
Panama City 1
Redmond 1
Salerno 1
Serio 1
Shenzhen 1
Volla 1
Walnut 1
Zagreb 1
Totale 473
Nome #
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 45
TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation 42
Sviluppo di un sistema di microscopia time-lapse per lo studio della motilità cellulare in vitro 41
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition 38
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 37
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 37
Inhaled medications in cystic fibrosis beyond antibiotics 36
Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis. 34
Defective proteostasis in celiac disease as a new therapeutic target 32
Cystic fibrosis: a disorder with defective autophagy 31
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease 31
Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease. 30
Development of a cell motility characterization system for industrial biotechnological applications 29
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. 29
Towards a rational combination therapy of cystic fibrosis: How cystamine restores the stability of mutant CFTR 28
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. 28
Probiotics Supplements Reduce ER Stress and Gut Inflammation Associated with Gliadin Intake in a Mouse Model of Gluten Sensitivity. 26
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator 24
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. 21
Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect. 19
Collective rotational motion of freely expanding T84 epithelial cell colonies 19
Early tissue transglutaminase mediated response underlies k562(s) cells gliadin – dependent agglutination 15
Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. 15
Immuno-Sensing at Ultra-Low Concentration of TG2 Protein by Organic Electrochemical Transistors 14
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 12
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 10
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 10
Organic Electrochemical Transistor Immuno-Sensors for Spike Protein Early Detection 9
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 8
Totale 750
Categoria #
all - tutte 4.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 6 0 0 0 0 4 8 6
2020/202135 2 2 5 4 6 2 2 2 3 3 1 3
2021/2022148 0 0 0 0 0 37 1 2 12 4 34 58
2022/2023204 28 35 2 10 27 27 0 18 27 15 14 1
2023/2024157 17 24 22 9 7 11 7 12 1 8 25 14
2024/202598 39 44 1 1 13 0 0 0 0 0 0 0
Totale 750